United States · Series A startup

Who invested in Acylin Therapeutics

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$6.4Mraised across 2 rounds since 2011, from 2 sources

$4.4MSeries A$2.0MSeries A
Latest round
Series A, $2.0MJun 2012
Biggest round
$4.4MSeries A · Jan 2011
Investors
4
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20112012
$4.4MSeries A$2.0MSeries A
First round
Series A, $4.4M
Jan 2011
Biggest round
$4.4M
Series A · Jan 2011
Between rounds
17 months
from the last two

The rounds

  1. Jun 2012
    Series A$2.0M

    No investor was named in the report.

    Reported by sec.govSEC filing: $2.0M sold, first sale May 2012

  2. Jan 2011
    Series A$4.4M4 new

    Reported by onbiovc.comSEC filing: $2.0M sold, first sale Nov 2010

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

AmgenCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Acylin Therapeutics

Who invested in Acylin Therapeutics?

Acylin Therapeutics's investors include ARCH Venture Partners, Alexandria Real Estate Equities, OVP Venture Partners and Amgen.

How much has Acylin Therapeutics raised?

Acylin Therapeutics has raised $6.4M across 2 rounds since 2011.

When did Acylin Therapeutics last raise?

Acylin Therapeutics's most recent round was a Series A of $2.0M in Jun 2012.

What was Acylin Therapeutics's biggest round?

Acylin Therapeutics's largest round on record is $4.4M (Series A), in Jan 2011.

Who backed Acylin Therapeutics first?

Acylin Therapeutics's first round on record, in Jan 2011, was backed by ARCH Venture Partners, Alexandria Real Estate Equities and OVP Venture Partners and 1 others.

What stage is Acylin Therapeutics at?

Acylin Therapeutics's latest named round is a Series A, in Jun 2012.

Where is Acylin Therapeutics based?

Acylin Therapeutics is based in the United States.

Companies like Acylin Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.